Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

• Autori principali: Qi-An Chen (Autore), Wei-Hao Lin (Autore), Xiao-Xiang Zhou (Autore), Zheng Cao (Autore), Xiao-Li Feng (Autore), Yi-Bo Gao (Autore), Jie He (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2024-02-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...